Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab, bevacizumab, and cyclophosphamide in recurrent ovarian, fallopian tube, or primary peritone…
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) [Phase 3]
Phase 3 trial investigating stratified evaluation of PDS and NACT-IDS in ovarian cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine to investigator's choice chemotherapy in FR alpha-positive advanced epithelial ovarian, pr…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of everolimus and letrozole in patients with recurrent hormone receptor-positive ovarian…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for cabozantinib-s-malate in recurrent or progressive ovarian, fallopian tube, or primary peritoneal cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer [Phase 2]
Phase 2 trial update evaluating weekly carboplatin and docetaxel for recurrent ovarian or primary peritoneal cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without viral therapy in recurrent or persistent ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating elesclomol sodium with paclitaxel in patients with recurrent or persistent ovarian epithelial cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating sorafenib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in recurrent or persistent ovarian, fallopian tube, endometrial, or peritoneal cancers; study terminated …
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating HIPEC as neoadjuvant chemotherapy and postoperative chemotherapy for advanced epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for EGEN-001 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for platinum-resistant/refractory, paclitaxel-pretreated recurrent ovarian and peritoneal carcinoma; study terminated w…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients [Phase 1]
A Phase 1 clinical trial update evaluating therapeutic targeting of stress factors in ovarian cancer; status is completed.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]
Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update on combination chemotherapy for stage III/IV ovarian epithelial cancer or primary peritoneal cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study evaluating the combination of irinotecan and bevacizumab in recurrent ovarian cancer (including fallopian tube cancer and pr…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer [Phase 2]
Phase 2 clinical trial evaluating selumetinib sulfate in women with recurrent low-grade ovarian or peritoneal serous carcinomas has complete…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]
Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; st…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for pazopanib/doxorubicin in relapsed platinum-sensitive or resistant ovarian, fallopian tube, or primary peritoneal a…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Ramucirumab in Ovarian Cancer [Phase 2]
Phase 2 trial update of ramucirumab in ovarian cancer and related gynecologic cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…